Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Infect Immun ; 69(5): 2888-93, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11292703

RESUMEN

Vaccination by anthrax protective antigen (PA)-based vaccines requires multiple immunization, underlying the need to develop more efficacious vaccines or alternative vaccination regimens. In spite of the vast use of PA-based vaccines, the definition of a marker for protective immunity is still lacking. Here we describe studies designed to help define such markers. To this end we have immunized guinea pigs by different methods and monitored the immune response and the corresponding extent of protection against a lethal challenge with anthrax spores. Active immunization was performed by a single injection using one of two methods: (i) vaccination with decreasing amounts of PA and (ii) vaccination with constant amounts of PA that had been thermally inactivated for increasing periods. In both studies a direct correlation between survival and neutralizing-antibody titer was found (r(2) = 0.92 and 0.95, respectively). Most significantly, in the two protocols a similar neutralizing-antibody titer range provided 50% protection. Furthermore, in a complementary study involving passive transfer of PA hyperimmune sera to naive animals, a similar correlation between neutralizing-antibody titers and protection was found. In all three immunization studies, neutralization titers of at least 300 were sufficient to confer protection against a dose of 40 50% lethal doses (LD(50)) of virulent anthrax spores of the Vollum strain. Such consistency in the correlation of protective immunity with anti-PA antibody titers was not observed for antibody titers determined by an enzyme-linked immunosorbent assay. Taken together, these results clearly demonstrate that neutralizing antibodies to PA constitute a major component of the protective immunity against anthrax and suggest that this parameter could be used as a surrogate marker for protection.


Asunto(s)
Antígenos Bacterianos , Bacillus anthracis/inmunología , Toxinas Bacterianas/inmunología , Vacunas Bacterianas/inmunología , Animales , Anticuerpos Antibacterianos/sangre , Ensayo de Inmunoadsorción Enzimática , Femenino , Cobayas , Sueros Inmunes/inmunología , Inmunoglobulina G/sangre , Vacunación
2.
J Biolumin Chemilumin ; 8(5): 261-6, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-7993392

RESUMEN

htpR- (rpoH, sigma 32 minus) strain of E. coli harbouring the whole lux system of Vibrio fischeri is very dim. We have recently shown that GroESL proteins fully recover the expression of the lux system in this strain. This work has been undertaken to study our assumption that the GroESL proteins stabilize the LuxR protein, thus enhancing the formation of LuxR-Inducer complex. E. coli htpR- cells harbouring the luxR gene were unable to bind extracellularly added inducer, while late logarithmically growing htpR+ strain bound small quantities of the inducer. Reduction in the nutrient content of the growth medium resulted in a large increase in the capability of these cells to bind the inducer. htpR+ or htpR- E. coli strains harbouring both the luxR and the groESL genes bound large quantities of the inducer. The molecular and ecological significance of these results is discussed.


Asunto(s)
Proteínas Bacterianas/metabolismo , Chaperoninas/metabolismo , Escherichia coli/metabolismo , Proteínas de Choque Térmico/metabolismo , Proteínas Represoras , Transactivadores , Factores de Transcripción/metabolismo , Vibrio/genética , Proteínas Bacterianas/biosíntesis , Clonación Molecular , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Expresión Génica , Genes Bacterianos , Isopropil Tiogalactósido/farmacología , Cinética , Mediciones Luminiscentes , Plásmidos , Vibrio/metabolismo
3.
J Bacteriol ; 174(22): 7138-43, 1992 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1429436

RESUMEN

The transcription of the luminescence (lux) system of Vibrio fischeri is regulated by the LuxR protein and an autoinducer. We previously showed that apart from these regulatory elements, the transcription of the lux system is negatively controlled by the LexA protein and positively controlled by the HtpR protein (sigma 32). This study was conducted in order to elucidate the mode of action of the HtpR protein. Using luxR-lacZ fused genes, we showed that the HtpR protein is essential for the maximum expression of beta-galactosidase activity in Escherichia coli lac mutant cells. Using this construct, we also demonstrated that luxR is preferentially expressed toward the end of the logarithmic phase of growth. Starvation and addition of ethanol significantly advanced the appearance of beta-galactosidase activity in htpR+ cells. The luminescence system of E. coli htpR+ cells harboring the pChv1 plasmid with a deletion in the luxI gene is induced in the presence of low and constant concentrations (150 pg/ml) of the inducer only at a late stage of the logarithmic phase of growth. When the cellular LuxR content is reduced, following 23 generations of exponential growth in Luria broth, a mid-log-phase culture does not respond to the inducer (150 pg/ml). On the basis of the above observations we suggest that the HtpR protein controls the formation of V. fischeri LuxR protein. Preliminary findings indicate that the HtpR protein acts through the chaperonins GroESL. E. coli htpR/pChv1 cells retained their full level of in vivo and in vitro luciferase activities in the presence of multiple copies of groESL genes. The possibility that GroESL proteins stabilize the native form of LuxR protein is discussed.


Asunto(s)
Proteínas Bacterianas/biosíntesis , Proteínas Bacterianas/metabolismo , Chaperoninas/metabolismo , Genes Bacterianos , Proteínas de Choque Térmico , Proteínas Represoras , Serina Endopeptidasas , Factor sigma/metabolismo , Transactivadores , Factores de Transcripción , Vibrio/genética , Vibrio/metabolismo , Proteínas Bacterianas/genética , Chaperoninas/genética , Clonación Molecular , Escherichia coli/genética , Escherichia coli/crecimiento & desarrollo , Escherichia coli/metabolismo , Eliminación de Gen , Luciferasas/metabolismo , Mediciones Luminiscentes , Plásmidos , Secuencias Reguladoras de Ácidos Nucleicos , Mapeo Restrictivo , Factor sigma/genética , Transcripción Genética , Vibrio/crecimiento & desarrollo , beta-Galactosidasa/genética , beta-Galactosidasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA